DOI QR코드

DOI QR Code

Inhibitory Effect of Vitamin U (S-Methylmethionine Sulfonium Chloride) on Differentiation in 3T3-L1 Pre-adipocyte Cell Lines

  • Lee, Na Young (Arumdaun Nara Skin Clinic) ;
  • Park, Kui Young (Department of Dermatology, Chung-Ang University College of Medicine) ;
  • Min, Hye Jung (Department of Pathology, Chung-Ang University College of Medicine) ;
  • Song, Kye Yong (Department of Pathology, Chung-Ang University College of Medicine) ;
  • Lim, Yun Young (Department of Dermatology, Chung-Ang University College of Medicine) ;
  • Park, Juhee (Department of Dermatology, Chung-Ang University College of Medicine) ;
  • Kim, Beom Joon (Department of Dermatology, Chung-Ang University College of Medicine) ;
  • Kim, Myeung Nam (Department of Dermatology, Chung-Ang University College of Medicine)
  • Published : 2012.02.29

Abstract

Background: S-methylmethionine sulfonium chloride was originally called vitamin U because of its inhibition of ulceration in the digestive system. Vitamin U is ubiquitously expressed in the tissues of flowering plants, and while there have been reports on its hypolipidemic effect, its precise function remains unknown. Objective: This study was designed to evaluate the anti-obesity effect of vitamin U in 3T3-L1 pre-adipocyte cell lines. Methods: We cultured the pre-adipocyte cell line 3T3L1 to overconfluency and then added fat differentiation-inducing media (dexamethasone, IBMX [isobutylmethylxanthine], insulin, indomethacin) and different concentrations (10, 50, 70, 90, 100 mM) of vitamin U. Then, we evaluated changes in the levels of triglycerides (TGs), glycerol-3-phosphate dehydrogenase (G3PDH), AMP-activated protein kinase (AMPK), adipocyte-specific markers (peroxisome proliferator-activated receptor $\gamma$ [PPAR-$\gamma$], CCAAT/enhancer-binding protein $\alpha$ [C/EBP-$\alpha$], adipocyte differentiation and determination factor 1 [ADD-1], adipsin, fatty acid synthase, lipoprotein lipase) and apoptosis-related signals (Bcl-2, Bax). Results: There was a gradual decrease in the level of TGs, C/EBP-$\alpha$, PPAR-$\gamma$, adipsin, ADD-1 and GPDH activity with increasing concentrations of vitamin U. In contrast, we observed a significant increase in AMPK activity with increasing levels of vitamin U. The decrease in bcl-2 and increase in Bax observed with increasing concentrations of vitamin U in the media were not statistically significant. Conclusion: This study suggests that vitamin U inhibits adipocyte differentiation via downregulation of adipogenic factors and up-regulation of AMPK activity.

Keywords

References

  1. Spiegelman BM, Flier JS. Obesity and the regulation of energy balance. Cell 2001;104:531-543. https://doi.org/10.1016/S0092-8674(01)00240-9
  2. Spiegelman BM, Hu E, Kim JB, Brun R. PPAR gamma and the control of adipogenesis. Biochimie 1997;79:111-112. https://doi.org/10.1016/S0300-9084(97)81500-3
  3. Tontonoz P, Hu E, Spiegelman BM. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 1994;79:1147-1156. https://doi.org/10.1016/0092-8674(94)90006-X
  4. Umek RM, Friedman AD, McKnight SL. CCAAT-enhancer binding protein: a component of a differentiation switch. Science 1991;251:288-292. https://doi.org/10.1126/science.1987644
  5. Yeh WC, Cao Z, Classon M, McKnight SL. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev 1995;9:168-181. https://doi.org/10.1101/gad.9.2.168
  6. Kim JB, Spiegelman BM. ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes Dev 1996;10:1096-1107. https://doi.org/10.1101/gad.10.9.1096
  7. Ranganathan G, Unal R, Pokrovskaya I, Yao-Borengasser A, Phanavanh B, Lecka-Czernik B, et al. The lipogenic enzymes DGAT1, FAS, and LPL in adipose tissue: effects of obesity, insulin resistance, and TZD treatment. J Lipid Res 2006;47:2444-2450. https://doi.org/10.1194/jlr.M600248-JLR200
  8. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998;395:763-770. https://doi.org/10.1038/27376
  9. Rosen BS, Cook KS, Yaglom J, Groves DL, Volanakis JE, Damm D, et al. Adipsin and complement factor D activity: an immune-related defect in obesity. Science 1989;244:1483-1487. https://doi.org/10.1126/science.2734615
  10. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993;259:87-91. https://doi.org/10.1126/science.7678183
  11. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab 2000;11:327-332. https://doi.org/10.1016/S1043-2760(00)00301-5
  12. Sartipy P, Loskutoff DJ. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci USA 2003;100:7265-7270. https://doi.org/10.1073/pnas.1133870100
  13. Hardie DG, Scott JW, Pan DA, Hudson ER. Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett 2003;546:113-120. https://doi.org/10.1016/S0014-5793(03)00560-X
  14. Fryer LG, Carling D. AMP-activated protein kinase and the metabolic syndrome. Biochem Soc Trans 2005;33:362-366. https://doi.org/10.1042/BST0330362
  15. Kahn BB, Alquier T, Carling D, Hardie DG. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 2005;1:15-25. https://doi.org/10.1016/j.cmet.2004.12.003
  16. Roche-VITEC. Vitamin U. Pig News Info 1990;11:329-330.
  17. Gessler NN, Kharchenko LI, Pavlovskaia TE, Bykhovskii VIa. Radiation-protective effect of S-methylmethionine (vitamin U). Prikl Biokhim Mikrobiol 1996;32:666-668.
  18. Tomiyama K, Nakata H, Sasa H, Arimura S, Nishio E, Watanabe Y. Wortmannin, a specific phosphatidylinositol 3-kinase inhibitor, inhibits adipocytic differentiation of 3T3-L1 cells. Biochem Biophys Res Commun 1995;212:263-269. https://doi.org/10.1006/bbrc.1995.1965
  19. Towler MC, Hardie DG. AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res 2007;100:328-341. https://doi.org/10.1161/01.RES.0000256090.42690.05
  20. Dolinsky VW, Dyck JR. Role of AMP-activated protein kinase in healthy and diseased hearts. Am J Physiol Heart Circ Physiol 2006;291:H2557-2569. https://doi.org/10.1152/ajpheart.00329.2006
  21. Hwang JT, Park IJ, Shin JI, Lee YK, Lee SK, Baik HW, et al. Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase. Biochem Biophys Res Commun 2005;338:694-699. https://doi.org/10.1016/j.bbrc.2005.09.195

Cited by

  1. Digestive recovery of sulfur‐methyl‐l‐methionine and its bioaccessibility in Kimchi cabbages using a simulated in vitro digestion model system vol.94, pp.1, 2012, https://doi.org/10.1002/jsfa.6205
  2. 열풍건조 및 데침 처리에 따른 배암차즈기(Salvia plebeia R. Br.)의 항산화 및 이화학적 특성 변화 vol.43, pp.6, 2012, https://doi.org/10.3746/jkfn.2014.43.6.893
  3. AMP-Activated Protein Kinase: Maintaining Energy Homeostasis at the Cellular and Whole-Body Levels vol.34, pp.None, 2012, https://doi.org/10.1146/annurev-nutr-071812-161148
  4. Vitamin U, a novel free radical scavenger, prevents lens injury in rats administered with valproic acid vol.34, pp.9, 2012, https://doi.org/10.1177/0960327114561665
  5. Regulation of AMP-activated protein kinase by natural and synthetic activators vol.6, pp.1, 2012, https://doi.org/10.1016/j.apsb.2015.06.002
  6. The effect of vitamin U on the lung tissue of pentyleneterazole-induced seizures in rats vol.391, pp.2, 2012, https://doi.org/10.1007/s00210-017-1447-3
  7. Development of S-Methylmethionine Sulfonium Derivatives and Their Skin-Protective Effect against Ultraviolet Exposure vol.26, pp.3, 2018, https://doi.org/10.4062/biomolther.2017.109
  8. Brassica oleracea Prevents HCl/Ethanol-Induced Gastric Damages in Mice vol.11, pp.1, 2021, https://doi.org/10.3390/app11010016
  9. Antitumor and Antioxidant Activity of S-Methyl Methionine Sulfonium Chloride against Liver Cancer Induced in Wistar Albino Rats by Diethyl Nitrosamine and Carbon Tertrachloride vol.18, pp.18, 2021, https://doi.org/10.3390/ijerph18189726
  10. Modern approaches to pharmacotherapy of chronic gastritis vol.15, pp.None, 2012, https://doi.org/10.21518/2079-701x-2021-15-40-47